BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND IKZF1, LyF-1, 10320, ENSG00000185811, Q13422, Hs_54452, hIk-1, ZNFN1A1, IKAROS AND Prognosis
138 results:

  • 1. [The value of minimal residual disease and ikzf1 deletion for predicting prognosis in adult patients with B-cell acute lymphoblastic leukemia].
    Deng SY; Ou JW; Huang ZC; Chen JJ; Cai ZH; Liu QF; Zhou HS
    Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):257-263. PubMed ID: 38716597
    [No Abstract]    [Full Text] [Related]  

  • 2. Extracellular matrix protein 1 (ECM1) is a potential biomarker in B cell acute lymphoblastic leukemia.
    Wu LX; Zhao MY; Yan N; Zhou YL; Cao LM; Qin YZ; Jiang Q; Xu LP; Zhang XH; Huang XJ; Jiang H; Ruan GR
    Clin Exp Med; 2024 Mar; 24(1):56. PubMed ID: 38546916
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. KCTD5 regulates ikaros degradation induced by chemotherapeutic drug etoposide in hematological cells.
    Ma L; Yin C; Zhang Y; Li J; Shi L; Zhou T; Huang X; Liu Y; Cao J; Wu G; Gu H; He L
    Biol Chem; 2024 May; 405(5):341-349. PubMed ID: 38424700
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. DNA Copy Number Alterations and Copy Neutral Loss of Heterozygosity in Adult Ph-Negative Acute B-Lymphoblastic leukemia: Focus on the Genes Involved.
    Risinskaya N; Gladysheva M; Abdulpatakhov A; Chabaeva Y; Surimova V; Aleshina O; Yushkova A; Dubova O; Kapranov N; Galtseva I; Kulikov S; Obukhova T; Sudarikov A; Parovichnikova E
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139431
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The clinical features and prognostic implications of PTPN11 mutation in adult patients with acute myeloid leukemia in China.
    Yang J; Zhao L; Wu Y; Niu T; Gong Y; Chen X; Huang X; Liu J; Dai Y; Ma H
    Cancer Med; 2023 Dec; 12(23):21111-21117. PubMed ID: 37937729
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Pre- and Postnatal Exposures to Tobacco Smoking and Survival of Childhood Acute Lymphoblastic and Myeloid leukemias in California, United States.
    Metayer C; Morimoto LM; Kang AY; Sanchez Alvarez J; Winestone LE
    Cancer Epidemiol Biomarkers Prev; 2024 Jan; 33(1):117-125. PubMed ID: 37921440
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Toblerone: detecting exon deletion events in cancer using RNA-seq.
    Lonsdale A; Halman A; Brown L; Kosasih H; Ekert P; Oshlack A
    F1000Res; 2023; 12():130. PubMed ID: 37767021
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Genes of Predisposition to Childhood Beta-Cell Acute Lymphoblastic leukemia in the Kazakh Population.
    Svyatova G; Boranbayeva R; Berezina G; Manzhuova L; Murtazaliyeva A
    Asian Pac J Cancer Prev; 2023 Aug; 24(8):2653-2666. PubMed ID: 37642051
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Genetic alterations and MRD refine risk assessment for KMT2A-rearranged B-cell precursor ALL in adults: a GRAALL study.
    Kim R; Bergugnat H; Pastoret C; Pasquier F; Raffoux E; Larcher L; Passet M; Grardel N; Delabesse E; Kubetzko S; Caye-Eude A; Meyer C; Marschalek R; Lafage-Pochitaloff M; Thiebaut-Bertrand A; Balsat M; Escoffre-Barbe M; Blum S; Baumann M; Banos A; Straetmans N; Gallego-Hernanz MP; Chalandon Y; Graux C; Soulier J; Leguay T; Hunault M; Huguet F; Lhéritier V; Dombret H; Boissel N; Clappier E
    Blood; 2023 Nov; 142(21):1806-1817. PubMed ID: 37595275
    [TBL] [Abstract] [Full Text] [Related]  

  • 10.
    Al-Zayan NR; Ashour MJ; Abuwarda HN; Sharif FA
    Pediatr Hematol Oncol; 2024; 41(2):103-113. PubMed ID: 37578068
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Outlier Expression of Isoforms by Targeted or Total RNA Sequencing Identifies Clinically Significant Genomic Variants in Hematolymphoid Tumors.
    Tsai HK; Gogakos T; Lip V; Tsai JM; Li YD; Fisch AS; Weiss J; Yang W; Grimmett L; DiToro D; Schaefer EJ; Lindsley RC; Tran TH; Caron M; Langlois S; Sinnett D; Pikman Y; Nardi V; Kim AS; Silverman LB; Harris MH
    J Mol Diagn; 2023 Sep; 25(9):665-681. PubMed ID: 37419244
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Identification of ikzf1 genetic mutations as new molecular subtypes in acute myeloid leukaemia.
    Wang Y; Cheng W; Zhang Y; Zhang Y; Sun T; Zhu Y; Yin W; Zhang J; Li J; Shen Y
    Clin Transl Med; 2023 Jun; 13(6):e1309. PubMed ID: 37345307
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Acute leukemias with complex karyotype show a similarly poor outcome independent of mixed, myeloid or lymphoblastic immunophenotype: A study from the Bone Marrow Pathology Group.
    Kirtek T; Chen W; Laczko D; Bagg A; Koduru P; Foucar K; Venable E; Nichols M; Rogers HJ; Tam W; Orazi A; Hsi ED; Hasserjian RP; Wang SA; Arber DA; Weinberg OK
    Leuk Res; 2023 Jul; 130():107309. PubMed ID: 37210875
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The prognostic impact of ikzf1 deletions and UKALL genetic classifiers in paediatric B-cell precursor acute lymphoblastic leukaemia treated according to NOPHO 2008 protocols.
    Öfverholm I; Rezayee F; Heyman M; Harila A; Arvidsson L; Schmiegelow K; Norén-Nyström U; Barbany G
    Br J Haematol; 2023 Jul; 202(2):384-392. PubMed ID: 37156607
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Prevalence and prognostic significance of ikzf1 deletion in paediatric acute lymphoblastic leukemia: A systematic review and meta-analysis.
    Srinivasan S; Ramanathan S; Kumar S; Peyam S; Radhakrishnan V
    Ann Hematol; 2023 Aug; 102(8):2165-2179. PubMed ID: 37154889
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The prognostic value of ikzf1
    Kicinski M; Arfeuille C; Grardel N; Bakkus M; Caye-Eude A; Plat G; Ferster A; Uyttebroeck A; De Moerloose B; Rohrlich P; Suciu S; Bertrand Y; Cavé H
    Pediatr Blood Cancer; 2023 Jun; 70(6):e30313. PubMed ID: 36971444
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Contributions of ARID5B, ikzf1, PIP4K2A, and GATA3 Gene Polymorphisms to Childhood Acute Lymphoblastic leukemia in a Chinese Population.
    Liu X; Xiao M; Xing Z; Jiang H; Zhu C; Zhang X; Li W; Wang Z; Wu F; Chen Y
    J Pediatr Hematol Oncol; 2023 Apr; 45(3):123-129. PubMed ID: 36952466
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Integrative genomic analysis of childhood acute lymphoblastic leukaemia lacking a genetic biomarker in the UKALL2003 clinical trial.
    Schwab C; Cranston RE; Ryan SL; Butler E; Winterman E; Hawking Z; Bashton M; Enshaei A; Russell LJ; Kingsbury Z; Peden JF; Barretta E; Murray J; Gibson J; Hinchliffe AC; Bain R; Vora A; Bentley DR; Ross MT; Moorman AV; Harrison CJ
    Leukemia; 2023 Mar; 37(3):529-538. PubMed ID: 36550215
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Genetic landscape of chronic myeloid leukemia.
    Ochi Y
    Int J Hematol; 2023 Jan; 117(1):30-36. PubMed ID: 36477676
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Transcriptome-based molecular subtypes and differentiation hierarchies improve the classification framework of acute myeloid leukemia.
    Cheng WY; Li JF; Zhu YM; Lin XJ; Wen LJ; Zhang F; Zhang YL; Zhao M; Fang H; Wang SY; Lin XJ; Qiao N; Yin W; Zhang JN; Dai YT; Jiang L; Sun XJ; Xu Y; Zhang TT; Chen SN; Zhu HH; Chen Z; Jin J; Wu DP; Shen Y; Chen SJ
    Proc Natl Acad Sci U S A; 2022 Dec; 119(49):e2211429119. PubMed ID: 36442087
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 7.